AIMS The aim of this study was to examine health-care professionals attitudes towards implantable cardioverter-defibrillator (ICD) therapy and issues discussed with patients. METHODS AND RESULTS Survey of 209 health-care professionals providing specialized treatment and care of ICD patients at the five implanting centres in Denmark. Questions pertained to gender, age, years of experience with...

Our previous studies revealed an inhibitory effect of ICD-85 (Venom derived peptides) on breast cancer cell line MDA-MB231. ICD-85 was also confirmed by in-vivo studies to suppress the breast tumor in mice. However, the exact mechanism of ICD-85 was unknown. Hence, the present study was undertaken to assess the mechanism of ICD-85 effect as an anti-proliferative agent of cancer cells. The effec...

Current guidelines for implantable cardioverter-defibrillator (ICD) therapy in heart failure patients were established by multiple device trials; however, very few geriatric patients (patients ≥ 65 years old) were included in these studies. This article explores the controversies of ICD implantation in the geriatric population, management of delivered ICD therapy in this age group, and the end ...

This paper describes the medical NLP system developed at Dublin City University for participation in the Second Medical NLP Shared Task (MedNLP 2) in NTCIR-11 [1]. This shared task is a Japanese task. Our system detects International Classification of Diseases (ICD) and time entities and classifies ICD entities. We participated in the task 1 which detects the ICD and time entities, and the task...

Introduction The implantable cardioverter-defibrillator (ICD) has reduced mortality in survivors of sudden cardiac arrest and patients at high risk of sudden cardiac death. This benefit comes at the cost of device-related complications, including those related to transvenous leads. The subcutaneous ICD (S-ICD) is an alternative to the conventional transvenous ICD (TV-ICD) system and has no tran...

Despite the impressive development of medical therapies for patients with myocardial dysfunction, sudden cardiac death (SCD) is still too frequent. In patients with severe cardiomyopathies the insertion of an implantable cardiac defibrillator (ICD) has been shown to reduce SCD risk (1). For primary prevention in patients with left ventricular ejection fraction (LVEF) below 35%, ICD is now recom...

BACKGROUND Implantable cardioverter-defibrillator (ICD) therapy is associated with improved outcomes in patients with heart failure (HF), but whether this association holds among older patients with multiple comorbid illnesses and worse HF burden remains unclear. METHODS AND RESULTS Using the National Cardiovascular Data Registry's ICD Registry and the Get With The Guidelines-Heart Failure (G...

BACKGROUND Little is known about gender differences in the response to implantable cardioverter defibrillator (ICD) therapy. We compared female and male ICD patients on anxiety, depression, health-related quality of life (HRQL), ICD concerns, and ICD acceptance. METHODS A cohort of consecutive, surviving patients (n = 535; mean age = 61.5 +/- 14.4, 81.9% male) implanted with an ICD between 19...

BACKGROUND We have previously described a method for dealing with missing data in a prospective cardiac registry initiative. The method involves merging registry data to corresponding ICD-9-CM administrative data to fill in missing data 'holes'. Here, we describe the process of translating our data merging solution to ICD-10, and then validating its performance. METHODS A multi-step translati...

BACKGROUND Randomized studies of implantable cardioverter defibrillators (ICD) have excluded sudden cardiac death survivors who had revascularization before or after an arrhythmic event. To evaluate the role of ICD and the effects of clinical variables including degree of revascularization, we studied cardiac surgery patients who had an ICD implanted for sustained perioperative ventricular arrh...